Sales and Marketing

Showing 15 posts of 11527 posts found.

Actavis confirms retirement of its comms officer

April 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, charles mayr

Ireland-based pharma firm Actavis has announced its chief communications officer Charles Mayr (pictured) is to retire shortly due to health …

Novartis heart drug steps closer to EAMS scheme

April 23, 2015 Sales and Marketing LCZ696, MHRA, Medicines and Healthcare products Regulatory Agency, NICE, eams, pim, sacubitril/valsartan

Novartis’ investigational heart failure drug LCZ696 has been handed a Promising Innovative Medicine designation (PIM) after showing that it significantly …

Novartis and Abbott start year with strong Q1 sales

April 23, 2015 Sales and Marketing Abbott, Amgen, Cosentyx, GSK, Neupogen, Novartis, Secukinumab, Zarxio, biosimilar, filgrastim, financials

Novartis and Abbott have both posted strong first-quarter results and made bullish predictions about their financial performance in 2015. Novartis …

Novo Nordisk obesity drug is launched in the US

April 23, 2015 Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

Gilead presents new Sovaldi data

April 23, 2015 Sales and Marketing GS-5816, GS-9857, Gilead, NS3/4A, SVR12, hepatitis C, sofosbuvir, sovaldi

Gilead is looking to several new studies to support future new Sovaldi combinations and broadened treatment groups for its hepatitis …

Boehringer assures future growth following sales drop

April 23, 2015 Sales and Marketing Boehringer, COPD, Glyxambi, Striverdi Respimat, empagliflozin, empagliflozin/linagliptin, financials, full year, jardiance, nintedanib, ofev, olodaterol, results

Boehringer says it is positioned for future growth in the wake of filing a decline in profit for 2014 and …

Cristal Therapeutics hires chief business officer from Merck

April 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck

Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …

Study reveals true scale of falsified medicines problem

April 22, 2015 Manufacturing and Production, Sales and Marketing Counterfeiting, fake, falsified medicines, health, pharma, supply chain

The full scope and prevalence of counterfeit medicines is poorly understood, according to a study of global pharma supply chains. …

Amgen files high earnings for Q1

April 22, 2015 Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis

Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …

Teva faces $512m fine in generic Provigil row

April 22, 2015 Sales and Marketing Cephalon, Mylan, Teva, generic, modafinil, provigil

Teva has agreed to a record $512 million settlement in a ‘pay-to-delay’ row over generic versions of its drug Provigil. …

Roche buoyed by cancer drug sales

April 22, 2015 Sales and Marketing Actemra, Cancer, Esbriet, Esbriet., MabThera, Q1, Rituxan, RoActemra, Roche, Xolair, avastin, oncology

Pharma’s biggest cancer drugs maker Roche has reported strong sales growth on the back of its oncology portfolio for its …

Two oncology successes for Pfizer

April 22, 2015 Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology

Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …

Boehringer Ingelheim and Bayer ‘taking the lead’ in social media

April 22, 2015 Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld

Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …

EUSA Pharma appoints chief executive and director

April 22, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley

Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …

Teva moves to buy Mylan

April 21, 2015 Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
The Gateway to Local Adoption Series

Latest content